#332 Inpatient Covid Management with Dr. Nathan Erdmann

In this episode of The Curbsiders, Drs. Matthew Watto and Paul Nelson-Williams, along with guest host Dr. Moni Amin, interview Dr. Nathan Erdmann about inpatient COVID-19 management. Dr. Erdmann discusses the importance of clinical context over trending labs and the two main approaches to managing COVID-19: antiviral treatment and immunomodulation. The conversation covers admission criteria, outpatient therapeutics (including monoclonal antibodies and oral antivirals), and the use of remdesivir. They delve into the nuances of using inflammatory markers, the role of steroids, and the potential for additional immunomodulators like JAK inhibitors. The discussion also addresses anticoagulation strategies, the low rate of secondary bacterial infections, and considerations for vaccination post-COVID-19 infection. Dr. Erdmann emphasizes the importance of tailoring treatment to individual patients, especially those who are immunocompromised, and provides key take-home points for internists managing COVID-19 cases.

Outlines

Part 1: Introduction and Case Presentation

Part 2: Treatment Strategies and Considerations

Part 3: Outcomes, Long COVID, and Future Prevention

Sign in to continue reading, translating and more.

Continue

The Curbsiders Internal Medicine Podcast

Part 1: Introduction and Case Presentation

Introduction to Inpatient COVID Management and Guest Introduction

Cultural Preferences, Advice on Saying "No," and Disclosure

Pick of the Week, Sponsor Mention, and Initial COVID Case Discussion

Part 2: Treatment Strategies and Considerations

Antibody Options, Oral Antivirals, and Patient Stratification

Risk Assessment, Inflammatory Markers, and Treatment Strategies

Steroid Use, Dosing, and Alternative Immunomodulators

Remdesivir Recommendations, Study Evaluation, and Inflammatory Markers

CTPE Considerations, Anticoagulation, and Antibacterial Use

Part 3: Outcomes, Long COVID, and Future Prevention

Ms. Patel's Course, Long COVID, and Pulmonary Follow-Up

Booster Vaccines, Patient Communication, and Key Takeaways

Outro and Credits

#332 Inpatient Covid Management with Dr. Nathan Erdmann

The Curbsiders Internal Medicine Podcast

Part 1: Introduction and Case Presentation

00:04Introduction to Inpatient COVID Management and Guest Introduction

Introduction to Inpatient COVID Management and Guest Introduction

04:25Cultural Preferences, Advice on Saying "No," and Disclosure

Cultural Preferences, Advice on Saying "No," and Disclosure

06:51Pick of the Week, Sponsor Mention, and Initial COVID Case Discussion

Pick of the Week, Sponsor Mention, and Initial COVID Case Discussion

Part 2: Treatment Strategies and Considerations

13:36Antibody Options, Oral Antivirals, and Patient Stratification

Antibody Options, Oral Antivirals, and Patient Stratification

18:29Risk Assessment, Inflammatory Markers, and Treatment Strategies

Risk Assessment, Inflammatory Markers, and Treatment Strategies

25:39Steroid Use, Dosing, and Alternative Immunomodulators

Steroid Use, Dosing, and Alternative Immunomodulators

32:26Remdesivir Recommendations, Study Evaluation, and Inflammatory Markers

Remdesivir Recommendations, Study Evaluation, and Inflammatory Markers

39:19CTPE Considerations, Anticoagulation, and Antibacterial Use

CTPE Considerations, Anticoagulation, and Antibacterial Use

Part 3: Outcomes, Long COVID, and Future Prevention

45:59Ms. Patel's Course, Long COVID, and Pulmonary Follow-Up

Ms. Patel's Course, Long COVID, and Pulmonary Follow-Up

53:09Booster Vaccines, Patient Communication, and Key Takeaways

Booster Vaccines, Patient Communication, and Key Takeaways

1:00:31Outro and Credits

Outro and Credits